Investigational Biologic Appears to Reduce Oral Corticosteroid Use in Severe Asthma
American Thoracic Society (ATS)An investigational biologic may reduce the need for adults with severe asthma to take an oral corticosteroid to control their asthma, according to a randomized controlled trial presented at the ATS 2017 International Conference. Study findings are being reported simultaneously online, ahead of print in the New England Journal of Medicine.